Outcome of Board Meeting held on January 24, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Mardia Samyoung Capillary Tubes Company Limited approved the unaudited standalone financial results for the quarter ended December 31, 2025 (Q3 FY26), along with the limited review report from statutory auditors S K Bhavsar & Co. Basic EPS for Q3 FY26 stood at approximately ₹1.85, compared to ₹0.02 in the previous quarter (Q2 FY26) and ₹0.21 in the year-ago quarter (Q3 FY25). For the nine months ended December 31, 2025, EPS was about ₹1.55 versus ₹0.39 in the corresponding nine months of the previous year. The company's business is reported under a single segment – Trading of Agriculture Products. The statutory auditor has drawn attention via an Emphasis of Matter paragraph regarding pending comprehensive verification of Trade Receivables, Trade Payables, and Loans & Advances balances, including direct confirmations and reconciliation steps that are still in progress.
The strong quarter-on-quarter EPS jump is a positive signal, but the auditor's emphasis on unverified receivables, payables, and loan balances is a yellow flag that investors should monitor, as it introduces uncertainty over the true quality and recoverability of reported assets.